Despite 311 Pages of Criticism, NASA Still Won't Cancel the Boeing Starliner

A 311-page NASA report found Boeing's 2024 Crewed Flight Test a mission failure, identifying four critical propulsion defects (five service-module thrusters and one crew-module thruster failed; seven of eight helium manifold seals leaked) and a lack of redundancy, and classifying the incident as a Type A mishap with 61 formal recommendations. NASA has suspended further crew flights on Starliner until causes are corrected and the propulsion system is qualified, leaving Boeing’s $4.2B Commercial Crew program at risk of losing at least ~$1B in revenue if ISS retirement proceeds in 2030 and undermining Boeing's space reputation. Continued grounding could limit Starliner to uncrewed cargo runs (or permanent sidelining) and preserve SpaceX’s pricing/market advantage absent a viable Boeing competitor.

Analysis

This is a classic redundancy-versus-competition outcome: NASA's public decision to keep Boeing alive preserves strategic optionality for the agency but materially raises the probability that Boeing will be forced to accept onerous corrective terms (price concessions, extended performance bonds, milestone-based payments). That shifts near-term cash flow risk from schedule slippage into contract renegotiation risk — your homerun scenario for Boeing now requires successful technical fixes plus political/contractual wins, not just engineering execution.

Second-order winners are the non-public rivals and downstream logistics providers who can monetize lengthened exclusivity windows or higher per-seat pricing from SpaceX; public proxies are defense primes with stable, non-ISS-funded revenue and testing/ground-services companies that can pick up work if Starliner is sidelined. Suppliers heavily exposed to Starliner avionics/propulsion face inventory write-down and backlog compression risk inside 2-8 quarters, creating an identifiable hit to cyclical aerospace supply chain cashflows.

Key catalysts to watch on a 1-24 month timeline: NASA acceptance of Boeing’s corrective action plan, independent certification milestones, congressional hearings/appropriations language, and ISS life-extension decisions (2030 vs 2032) — each materially re-prices Boeing’s remaining program economics. Tail outcomes range from a multi-quarter operational pause that trims ~mid-single-digit percentage points off Boeing’s near-term aerospace margin to program cancellation that would inflict a concentrated ~$1bn+ revenue hit plus reputational spillovers into future DOD/FAA procurement windows.

Key Decisions for Investors

• Establish a tactical bearish position on BA via a 12–24 month put spread (size 1–2% NAV): buy longer-dated puts to capture a 20–40% downside scenario while selling nearer strikes to finance premium. R/R: limited known premium outlay vs asymmetric downside if certification stalls or contract revenue is clawed back.
• Pair trade: short BA (smaller notional) and go long a large defense prime (LMT or RTX) for 12–24 months — size the pair to be market neutral. Rationale: defense primes trade on stable backlog and will be preferred for risk-off budget reallocation; payoff if Boeing loses share or takes pricing concessions.
• Rotate a small tranche into secular growth (NFLX) over 6–18 months funded by reducing BA exposure: buy NFLX or near-dated LEAP calls to hedge portfolio beta. R/R: protects portfolio cyclicality while capturing thicker growth premium; main risk is consumer demand compression.
• De-risk credit exposure: reduce duration/weight in BA corporate debt holdings and avoid adding unsecured exposure until Boeing clears major NASA milestones (watch for remediation sign-off). R/R: preserves capital against idiosyncratic credit widening; cost is lower yield capture in near-term.